Gravitoncorp
1 known investors
Graviton Bioscience develops small-molecule therapies, including selective ROCK2 inhibitors, targeting fibrotic, autoimmune, and central nervous system diseases. The company has a pipeline of drug candidates in development, such as GV101, aimed at treating conditions like liver fibrosis and obesity.
Investors · 1
Frequently asked questions
- What does Gravitoncorp do?
- Graviton Bioscience develops small-molecule therapies, including selective ROCK2 inhibitors, targeting fibrotic, autoimmune, and central nervous system diseases. The company has a pipeline of drug candidates in development, such as GV101, aimed at treating conditions like liver fibrosis and obesity.
- Who are Gravitoncorp's investors?
- Gravitoncorp's investors include Pontifax Venture Capital.